USP is developing new guidelines to help organizations prioritize risk and ensure raw material quality.
Fouad Atouf, PhD
Advertisement
Articles by Fouad Atouf, PhD
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
Advertisement
Latest Updated Articles
- USP Publishes Monoclonal Antibody Guidelines
Published: March 2nd 2015 | Updated:
The Role of Quality Standards for Biomanufacturing Raw MaterialsPublished: August 2nd 2017 | Updated:
- Managing Risk for Biomanufacturing Raw Materials
Published: September 6th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
